Page
%P
-
Protocol
Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus
The advent of direct-acting antivirals (DAAs) has brought about a sudden renaissance in the treatment of chronic hepatitis C virus (HCV) infection with SVR rates now routinely >90%. However, due to the error-p...